期刊文献+

肢体和躯干体壁软组织肉瘤患者术后IMRT疗效分析

Therapeutic effect of postoperative intensity-modulated radiotherapy in patients with soft tissue sarcomas of the extremities and trunk wall
原文传递
导出
摘要 目的分析术后IMRT对肢体和躯干软组织肉瘤患者疗效。方法回顾分析2005—2011年收治的80例肢体和躯干体壁软组织肉瘤患者资料。全组患者功能保全手术后均行IMRT,其中原发肢体的51例,原发躯干体壁的29例。7l例患者获得阴性手术切缘。中位放疗剂量为64Gy。Kaplan—Meier法计算生存率并Logrank法检验,Cox模型多因素预后分析。结果5年样本数为43例,5年LC率为88%、DMFS率为75%、PFS率为73%、OS率为84%。手术切缘阴性者5年LC率显著高于阳性切缘者(90%比65%。P=0.023),原发肿瘤≤5cm者的5年OS率显著高于〉5cm者(95%比69%.P=0.041)。多因素分析显示阳性切缘是LC率的影响因素(HR=5.33,95% CI为1.19~23.86,P=0.029)。随访期间水肿和关节僵硬总发生率分别为18%和10%。结论肢体和躯干体壁软组织肉瘤患者行术后IMRT可获得良好Lc率,远期不良反应发生率低。 Objective To investigate the therapeutic effect of postoperative intensity-modulated radiotherapy (IMRT) in patients with soft tissue sarcomas (STSs) of the extremities and trunk wall. Methods The clinical data of 80 patients with STSs of the extremities and trunk wall who were admitted and treated from 2005 to 2011 were analyzed retrospectively. All the patients received postoperative IMRT after conservation surgery, among whom 51 patients had primary lesions in the extremities and 29 had primary lesions in the trunk wall. Seventy-one patients achieved negative resection margin. The median dose of IMRT was 64 Gy. The Kaplan-Meier method was applied to calculate survival rates, the log-rank test was used for survival difference analysis, and the Cox proportional hazards model was applied for multivariate prognostic analysis. Results The 5-year sample size was 43. The 5-year local control (LC) rate, distant metastasis- free survival rate, progression-free survival rate, and 5-year overall survival (OS) rate were 88%, 75%, 73%, and 84%, respectively. The patients with negative resection margin had a significantly higher 5-year LC rate than those with positive resection margin (90% vs. 65%, P= 0. 023). The patients with primary tumor ≤ cm has a significantly higher 5-year OS rate than those with primary tumor〉5 cm (95% vs. 69%,P=0.041),multivariate.analysis revealed that positive resection margin was an independent risk factor for LC rate(HR=3.33,95% CI 1.19-23.86, P= 0. 029). During follow-up, the overall incidence rates of adema and joint steffess were 18% and 10%, respectively. Conclusions Patients with STSs of the extremities and trund wall can achieve a high LC rate after postoperative IMRT, with low incidence rates of hong-term adverse events.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2016年第1期46-49,共4页 Chinese Journal of Radiation Oncology
关键词 软组织肉瘤 肢体和躯干体壁 调强放射疗法 预后 晚期不良反应 Soft tissue sarcoma Extremities and trunk wall Intensity-modulated radiatmn therapy Local contral Late toxicity
  • 相关文献

参考文献21

  • 1Hong L, Alektiar KM, Hunt M, et al. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh [ J ]. Int J Radiat Oncol Bial Phys, 2004,59 ( 3 ) : 752-759. DOI: 10. 1016/j. ijrobp. 2003.11.037.
  • 2Bi XW, Li YX, Fang H, et al. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer' s ring: dosimetric analysis and clinical outcome [ J ]. Int J Radiat Oncol Biol Phys, 2013,87 ( 5 ) : 1086- 1093.DOI : 10.1016/j.ijrobp.2013.08.040.
  • 3Nutting CM, Morden JP, Harringtou KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT):a phase 3 multicentre randomised controlled trial [ J] .Lancet Onco1,2011,12(2) : 127-136.DOI : 10. 1016/$1470-2045 (10) 70290-4.
  • 4Folkert MR, Singer S, Brennan MF, et al. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity [ J ] .J Clin Onco1,2014, 32 ( 29 ) : 3236-3241. DO1: 10. 1200/JCO. 2013.53. 9452.
  • 5Alektiar KM, Hong L, Brennan MF, et al. Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results [ J ]. Int J Radiat Oneol Biol Phys, 2007,68 (2) :458-464.DOI : 10.1016/j.ijrobp.2006.12.054.
  • 6Alektiar KM, Brennan MF, Healey JH, et al. Impact of intensity- modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity [ J ]. J Clin Oncol, 2008,26 (20) : 3440- 3444. DO1:10.1200/JCO.2008.16.6249.
  • 7Lin C, Donaldson SS, Meza JL, et al. Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosareoma enrolled in COG DgsO 3--a report from the Children's Oncalogy Group [ J] .Int J Radiat Oncol Biol Phys ,2012,82 ( 5 ) : 1764-1770. DO1 : 10.1016/j. ijrobp. 2011. 01.036.
  • 8Yang JC, Dharmarajan KV, Wexler LH, et al. Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma [ J ]. Int J Radiat Oncol Biol Phys, 2012,84 ( 3 ) : e371-e377. DOI: 10.1016/j.ijrebp.2012.04.022.
  • 9NCI. Common terminology criteria for adverse events version 3.0 ( CTCAE ) [ Z ]. Bethesda, Maryland : National Institute of Health, 2003.
  • 10Yang JC, Chang AE, Baker AR, et al. Randomized prospeetive study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity [J].J Chn Oneol, 1998, 16 ( 1 ) : 197-203.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部